Business
Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Application Acceptance Notice for FZ-P001 Sodium Injection for Intraoperative Visualization of Malignant Lesions in Known or Suspected Lung Cancer Patients
Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Application Acceptance Notice for FZ-P001 Sodium Injection for Intraoperative Visualization of Malignant Lesions in Known or Suspected Lung Cancer Patients
About this update from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd. Class A
Announcement on Voluntary Disclosure of Receipt of the Clinical Trial Application Acceptance Notice for FZ-P001 Sodium Injection for Intraoperative Visualization of Malignant Lesions in Known or Suspected Lung Cancer Patients The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment